Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian H Rowley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Organic Letters|May 13, 2015
Arene oxidation with malonoyl peroxidesAndrei Dragan, Tomasz M Kubczyk, Julian H Rowley, et al.
Organic & Biomolecular Chemistry|February 14, 2013
Readily accessible chiral at nitrogen cage structuresJulian H Rowley, Sze Chak Yau, Benson M Kariuki, et al.
Organic & Biomolecular Chemistry|October 28, 2014
Improving catalyst activity in secondary amine catalysed transformationsJohn B Brazier, Timothy J K Gibbs, Julian H Rowley, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Organic Letters|May 13, 2015
Arene oxidation with malonoyl peroxidesAndrei Dragan, Tomasz M Kubczyk, Julian H Rowley, et al.
Organic & Biomolecular Chemistry|February 14, 2013
Readily accessible chiral at nitrogen cage structuresJulian H Rowley, Sze Chak Yau, Benson M Kariuki, et al.
Organic & Biomolecular Chemistry|October 28, 2014
Improving catalyst activity in secondary amine catalysed transformationsJohn B Brazier, Timothy J K Gibbs, Julian H Rowley, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 1